← Leaderboards
Daniel Hoft
Saint Louis University
$14,766,530
Attributed
$14,766,530
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.7M · FY2015–22$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$14,766,530 · 1
By mechanism
N01$14,766,530 · 1
Top collaborators
No co-investigators on record.
Most similar at Saint Louis University
Same institution · by research overlap
- Robert B. Belshe$24,085,110
- Daniel F. Hoft$50,608,486
- Robert Belshe$2,465,971
- William Siler$539,485
- Thomas J Chambers$1,805,248
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignContractsConduct Clinical TrialsResourcesNamed GroupEvaluationVaccinesProgramsCombatCommunicable DiseasesInfectious Disease TreatmentRouteInvestigationInfluenza Virus VaccinePhase I Clinical TrialsPhase I TrialOperationInfluenza A VirusProtocol DevelopmentVaccine TrialClinical Trials NetworkVaccine CandidateTuberculosisYellow Fever Virus
Grant awards (37)
Vaccine and Treatment Evaluation Units: Clinical Operations Support$94,591
N01 · FY2022 · AI · contact PI
Vaccine and Treatment Evaluation Unit: Phase I Trial of a Yellow Fever Virus Vaccine$5,000
N01 · FY2022 · AI · contact PI
VTEU: Phase II Clinical Trial to Evaluate Influenza Vaccines$5,000
N01 · FY2022 · AI · contact PI
Vaccine and Treatment Evaluation Units: Clinical Operations Support$176,867
N01 · FY2021 · AI · contact PI
Vaccine and Treatment Evaluation Units: Clinical Operations Support$175,011
N01 · FY2020 · AI · contact PI
Vaccine and Treatment Evaluation Units: Consultation and 'Omics Testing of Clinical Samples for a Yellow Fever Vaccine$166,700
N01 · FY2020 · AI · contact PI
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for a Natural History Challenge Study for Influenza$961,771
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for a Phase I Influenza Vaccine Trial$631,786
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Phase I Clinical Trial to Evaluate TB Therapeutics$622,751
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Clinical Operations Support$423,262
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Consultation and 'Omics Testing of Clinical Samples for a Phase I Influenza Vaccine Trial$405,891
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Phase I Clinical Trial to Evaluate a Universal Influenza Vaccine Candidate$55,989
N01 · FY2019 · AI · contact PI
VTEU: Phase I Clinical Trial to Evaluate a Universal Influenza Vaccine Candidate$1,740,342
N01 · FY2018 · AI · contact PI
VACCINE TREATMENT AND EVALUATION UNITS - PHASE I CLINICAL TRIAL TO EVALUATE TB THERAPEUTICS$860,187
N01 · FY2018 · AI · contact PI
Vaccine and Treatment Evaluation Units (VTEU): Concept and Protocol Development$741,174
N01 · FY2018 · AI · contact PI
VACCINE TREATMENT AND EVALUATION UNITS (VTEUS): CLINICAL OPERATIONS SUPPORT$227,858
N01 · FY2018 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS - PHASE I CLINICAL TRIAL TO EVALUATE TB THERAPEUTICS$120,360
N01 · FY2018 · AI · contact PI
Vaccine and Treatment Evaluation Unit: Malaria Vaccine Development$767,273
N01 · FY2017 · AI · contact PI
Vaccine and Treatment Evaluation Unit: Phase I Trial of a Yellow Fever Virus Vaccine$485,555
N01 · FY2017 · AI · contact PI
VACCINE TREATMENT AND EVALUATION UNIT: CLINICAL OPERATIONS SUPPORT$247,821
N01 · FY2017 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNIT: Phase 4 Tuberculosis Therapeutics Trial$219,240
N01 · FY2017 · AI · contact PI
VACCINE TREATMENT AND EVALUATION UNITS: CONCEPT AND PROTOCOL DEVELOPMENT$106,026
N01 · FY2017 · AI · contact PI
VTEU: ZIKA VIRUS NATURAL HISTORY STUDY$1,304,960
N01 · FY2016 · AI · contact PI
VTEU: Phase I Influenza Vaccine Clinical Trial$815,947
N01 · FY2016 · AI · contact PI
VTEU: Phase I Influenza Vaccine Clinical Trial$481,727
N01 · FY2016 · AI · contact PI
VTEU: Phase I Trial of Yellow Fever Virus Vaccines$316,699
N01 · FY2016 · AI · contact PI
VTEU: Phase II Influenza Vaccine Clinical Trial$53,681
N01 · FY2016 · AI · contact PI
Assay Work for Malaria Vaccines - VTEU$48,753
N01 · FY2016 · AI · contact PI
VTEU: Assay Work for Influenza Vaccines$30,442
N01 · FY2016 · AI · contact PI
Assay Work for Malaria Vaccines - VTEU$1,056,336
N01 · FY2015 · AI · contact PI
Phase I Trial of Yellow Fever Virus Vaccines - VTEU$366,924
N01 · FY2015 · AI · contact PI
Assay Work for Plague Vaccines - VTEU$299,974
N01 · FY2015 · AI · contact PI
Vaccine and Treatment Evaluation Unit$277,593
N01 · FY2015 · AI · contact PI
Assay Work for Herpes Vaccines - VTEU$274,978
N01 · FY2015 · AI · contact PI
Assay Work for TB Vaccines - VTEU$89,053
N01 · FY2015 · AI · contact PI
Phase I Trial of an Influenza Vaccine - VTEU$56,747
N01 · FY2015 · AI · contact PI
Assay Work for Influenza Vaccines - VTEU$52,261
N01 · FY2015 · AI · contact PI